Nessan Bermingham

Nessan Bermingham has an estimated net worth of $18.2 Million. This is based on reported shares across multiple companies, which include Intellia Therapeutics, Inc., F-star Therapeutics, Inc., and Korro Bio, Inc..

2017 was Nessan Bermingham's most active year for acquiring shares with 3 total transactions. Nessan Bermingham's most active month to acquire stocks was the month of October. 2017 was Nessan Bermingham's most active year for disposing of shares, totalling 5 transactions. Nessan Bermingham's most active month to dispose stocks was the month of February. 2017 saw Nessan Bermingham paying a total of $100,379.16 for 570,900 shares, this is the most they've acquired in one year. In 2017 Nessan Bermingham cashed out on 336,783 shares for a total of $7,000,019.24, their largest year based on trade value.